A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003)
Clinical trial NCT01732510 · TERMINATED
Trial details
- NCT number
- NCT01732510
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-21
- Primary completion
- 2014-10-20
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.